Recce Pharmaceuticals (ASX:RCE) Change In Inventory: A$0.00 Mil (TTM As of Dec. 2025)

What is Recce Pharmaceuticals Change In Inventory?

Recce Pharmaceuticals ASX:RCE +2.67% 31 Change In Inventory is A$0.00 Mil as of Dec. 2025. GuruFocus rates ASX:RCE with a GF Score™ of 31/100. The stock has 4 warning signs investors should review.

Recce Pharmaceuticals's change in inventory for the quarter that ended in Dec. 2025 was A$0.00 Mil. It means Recce Pharmaceuticals's inventory stayed the same from Jun. 2025 to Dec. 2025 .

Recce Pharmaceuticals's change in inventory for the fiscal year that ended in Jun. 2025 was A$0.00 Mil. It means Recce Pharmaceuticals's inventory stayed the same from Jun. 2024 to Jun. 2025 .

Recce Pharmaceuticals's Total Inventories for the quarter that ended in Dec. 2025 was A$0.00 Mil.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Inventory Turnover measures how fast the company turns over its inventory within a year.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Recce Pharmaceuticals (ASX:RCE) Change In Inventory Explanation

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Recce Pharmaceuticals's Days Inventory for the quarter that ended in is calculated as:

Days Inventory	=	Average Total Inventories	/	Cost of Goods Sold	*	Days in Period
	=	0	/	0	*	365 / 2
	=	N/A

2. Inventory Turnover measures how fast the company turns over its inventory within a year.

Recce Pharmaceuticals's Inventory Turnover for the quarter that ended in Dec. 2025 is calculated as

Inventory Turnover	=	Cost of Goods Sold	/	Average Total Inventories
	=	0	/	0
	=	N/A

3. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Recce Pharmaceuticals's Inventory to Revenue for the quarter that ended in Dec. 2025 is calculated as

Inventory-to-Revenue	=	Average Total Inventories	/	Revenue
	=	0	/	0
	=	N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Recce Pharmaceuticals Change In Inventory Related Terms

Recce Pharmaceuticals Change In Inventory Historical Data

* Premium members only.

The historical data trend for Recce Pharmaceuticals's Change In Inventory can be seen below:

Recce Pharmaceuticals Change In Inventory Chart

Recce Pharmaceuticals Annual Data

Trend

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Jun24

Jun25

Change In Inventory

Get a 7-Day Free Trial

0.00

Recce Pharmaceuticals Semi-Annual Data
	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24	Jun25	Dec25
Change In Inventory	Get a 7-Day Free Trial															0.00	0.00	0.00	0.00	0.00

31GF Score

Recce Pharmaceuticals Ltd ASX:RCE

Change In Inventory is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Recce Pharmaceuticals Change In Inventory Calculation

Change In Inventory is the difference between last period's ending inventory and the current period's ending inventory.

Change In Inventory for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$0.00 Mil.

Frequently Asked Questions Learn more about Change In Inventory →

What does a Change In Inventory of A$0.00 Mil mean?

Recce Pharmaceuticals (ASX:RCE) has a Change In Inventory of A$0.00 Mil as of Dec. 2025. Change in Inventory is the difference between current-period inventory and past-period inventory. View historical data for Recce Pharmaceuticals and its competitors.

Is Recce Pharmaceuticals' Change In Inventory too high?

Recce Pharmaceuticals' current Change In Inventory is A$0.00 Mil. Overall, Recce Pharmaceuticals has a GF Score™ of 31/100, reflecting its overall financial health beyond just this single metric.

How does Recce Pharmaceuticals' Change In Inventory compare to VRTX and REGN?

Recce Pharmaceuticals' Change In Inventory of A$0.00 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good Change In Inventory for a Biotechnology company?

A good Change In Inventory depends on the Biotechnology industry context. However, Change In Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high Change In Inventory mean?

A high Change In Inventory can signal that a stock is expensive relative to its fundamentals. Change in Inventory is the difference between current-period inventory and past-period inventory. View historical data for Recce Pharmaceuticals and its competitors. Recce Pharmaceuticals's current Change In Inventory is A$0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Recce Pharmaceuticals stock overvalued right now?

Recce Pharmaceuticals (ASX:RCE) has a current Change In Inventory of A$0.00 Mil. The current Change In Inventory is A$0.00 Mil. Recce Pharmaceuticals' overall GF Score™ is 31/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is Change In Inventory calculated?

Change In Inventory is calculated from a company's financial statements. For Recce Pharmaceuticals (ASX:RCE), the current Change In Inventory is A$0.00 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Recce Pharmaceuticals Business Description

Industry Healthcare Biotechnology

Comparable Companies ASX:DXB ASX:ACW ASX:ATH ASX:ILA ASX:LTP ASX:NYR ASX:PAR ASX:ALA ASX:IMM ASX:ATX VRTX REGN XBRU:UCB XBRU:ARGX XKRX:207940 ALNY ASX:CSL RVMD ONC MRNA

Other Exchanges R9Q:Germany

Address 3 Brodie Hall Drive, Suite 10, Technology Park, Bentley, WA, AUS, 6102

Website https://www.recce.com.au

Recce Pharmaceuticals Ltd is an Australia-based, globally-focused biotechnology company that is pioneering the development and commercialisation of a drug discovery and development business commercialising new Classes of synthetic anti-infectives with broad-spectrum activity designed to address the urgent health threat of antibiotic-resistant superbugs and emerging viral pathogens. Its patented candidate, RECCE 327, has been developed for the treatment of life-threatening bacterial infections. It has one segment, which is the research and development of pharmaceutical drugs. Geographic segments are Australia, the UK, and the USA, of which the majority of the revenue comes from Australia. It offers antibiotic drugs to treat bacterial infections for Sepsis, Escherichia coli, and Others.

31GF Score

Get the complete analysis for ASX:RCE

Change In Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

A$0.39

Price

View ASX:RCE Analysis

See Change In Inventory data for all stocks →